Zicam® Launches “Cold & Flu Companion” Mobile Application

Application Uses Location-Based Technology to Help Consumers Stay One Step Ahead of Cold and Flu

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Matrixx Initiatives, Inc., makers of Zicam® Cold Remedy, today announced the launch of the Zicam® Cold & Flu Companion mobile application for the T-Mobile G1™, the world’s first Android-powered phone. The same mobile application will be released for the iPhone in mid-December. The application enables on-the-go consumers to take charge of their health by checking cold and flu activity by zip code, among other features.

“The Cold & Flu Companion offers an innovative and customizable resource for consumers to prepare for the cold and flu season”

In time for the start of cold and flu season, this application allows active users to access up-to-date information from any location. On Tuesday, Nov. 11, Google launched Flu Trends, a Web service that can show if the number of flu cases is increasing in areas around the United States. The Zicam® Cold & Flu Companion mobile application provides greater detail than this service by showing users the percentage of sick people in any given zip code, what types of symptoms are most prevalent and which ones to look out for in a specific area. The application also keeps users updated on the latest cold and flu news. Zicam® Cold & Flu Companion provides vital information to keep consumers healthy and informed whether on the move around town, traveling for business or going on vacation, so they are prepared no matter where they are.

“The Cold & Flu Companion offers an innovative and customizable resource for consumers to prepare for the cold and flu season,” said Tim Connors, vice president of marketing at Matrixx Initiatives, Inc. “Knowing the latest cold and flu news and understanding the cold, flu and cough activity in a localized area can aid consumers in being aware of the risks around them.”

The application also provides a tool to receive valuable coupons for Zicam products and location-based directions identify nearby retailers where products can be purchased and coupons redeemed.

The application is currently available for Android-powered phones at the Android Marketplace on the user’s T-Mobile G1™ device and will be available in mid-December for the iPhone at the iTunes App Store (www.apple.com/iphone/appstore). To learn more about the Zicam® Cold & Flu Companion mobile application, visit www.zicam.com/tools/mobile.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam(R) and Nasal Comfort(TM) products in the cough and cold category, and Xcid(TM) antacid in the digestive health category. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal¹, and separately in the January 2003 issue of QJM: An International Journal of Medicine², the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Swabs(TM); Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Extreme Congestion Relief; Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to www.Zicam.com.

1 Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: A double-blind, placebo-controlled trial. Ear Nose Throat J. 2000;79:778-780, 782.

2 Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM. 2003;96:35-43.